Futures Edge Lower As NVDA Fallout Unsettles Tech Stocks — SLS, AMAT, CSCO, CADL Stocks In Focus
Cisco (CSCO) beat earnings estimates and raised its outlook, but shares fell 2.7% premarket. Microsoft (MSFT) had service outages, shares dropped 2.5%. Applied Materials (AMAT) reported strong results, shares up 0.35%. Sellas Life Sciences (SLS) rose 15% on trial results news. Candel Therapeutics (CADL) fell 34% due to FDA delays. Kraft Heinz (KHC) shares edged up 0.7%.
How this was made
The 30-second read
Why it matters
Combined earnings beats and operational setbacks create a mixed‑signal environment, with sector‑wide risk outweighing individual positives.
Market read
Tech earnings and operational news dominate premarket moves, with sector risk from Nvidia fallout influencing broader market direction.
What to watch
Potential rebound if Nvidia volatility eases; underlying demand growth remains strong for networking and semiconductor equipment.
Background
The article aggregates multiple company updates amid a broader tech market pullback triggered by Nvidia news.
Ticker impact
Cisco posted Q1 revenue $18.5B beating estimates and raised full-year outlook, but shares fell 2.7% premarket.
likely pressure as market prices in Nvidia‑related risk despite earnings beat
Strong results are offset by sector‑wide sell‑off after Nvidia news, driving short‑term downside.
Microsoft experienced multi‑hour outages in Outlook, Teams and Copilot, prompting a pause on deployments; shares fell 2.5% premarket.
likely pressure as investors react to operational issue
Outages affect core productivity suite revenue outlook, prompting immediate downside.
Applied Materials reported better‑than‑expected quarterly results and a record demand outlook, stock up 0.35% premarket.
likely modest upside as demand outlook remains strong
Positive earnings and growth guidance may attract buying, but broader tech volatility tempers move.
Sellas Life Sciences expects leukemia trial results later this month; stock jumped ~15% premarket.
likely upside as investors position for upcoming data release
Trial expectations drive speculative buying ahead of results.
Candel Therapeutics faces FDA delay on BLA filing, causing a 34% premarket drop.
likely pressure as delay reduces near‑term upside
FDA delay materially impacts valuation and timeline for product launch.
Kraft Heinz shares edged up 0.7% premarket after announcing a plan to return to growth.
likely slight upside as investors view turnaround plan favorably
Incremental news without concrete financial metrics limits impact.
Market effects
Tech sector faces heightened volatility after Nvidia fallout, affecting hardware and software stocks.
U.S. equity markets likely open lower on tech weakness.
Broad tech sentiment may influence overseas semiconductor and networking firms.
Counterpoint
Despite earnings beats, short positions could profit from continued sector sell‑off.
Key entities
- companyCisco Systems
Network equipment maker reporting Q1 earnings.
- companyMicrosoft
Software giant experiencing service outages.
- companyApplied Materials
Semiconductor equipment supplier with strong Q1 results.
- companySellas Life Sciences
Biotech awaiting leukemia trial data.
- companyCandel Therapeutics
Biotech facing FDA delay on prostate cancer therapy.
